Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
1.800
+0.008 (0.45%)
At close: May 8, 2026
Positron Market Cap
Positron has a market cap or net worth of $59.13 million as of May 8, 2026. Its market cap has increased by 20.30% in one year.
Market Cap
59.13M
Enterprise Value
57.99M
Revenue
461.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.80
Market Cap Chart
Since December 3, 1993, Positron's market cap has increased from 22.73M to 59.13M, an increase of 160.13%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 59.13M | 8.15% |
| Dec 31, 2025 | 54.67M | 98.24% |
| Dec 30, 2024 | 27.58M | -29.54% |
| Dec 29, 2023 | 39.14M | 88.62% |
| Dec 29, 2022 | 20.75M | -34.40% |
| Dec 31, 2021 | 31.63M | 1,169.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tian'an Technology Group | 168.42M |
| Zomedica | 90.20M |
| RetinalGenix Technologies | 75.02M |
| Vivos | 33.70M |
| Family Office of America | 33.22M |
| CS Diagnostics | 30.00M |
| PetVivo Holdings | 28.57M |
| Guided Therapeutics | 19.31M |